Cas 960287-36-9,(3S-trans)-3-((6-bromo-1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine

960287-36-9

Post Buying Request

Basic information

Product Name: (3S-trans)-3-((6-bromo-1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine
Synonyms: (3S-trans)-3-((6-bromo-1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine
CAS NO:960287-36-9
Molecular Formula:
Molecular Weight: 408.267
EINECS: N/A
Product Categories: N/A
Mol File: 960287-36-9.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (3S-trans)-3-((6-bromo-1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine(CAS DataBase Reference)
NIST Chemistry Reference: (3S-trans)-3-((6-bromo-1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine(960287-36-9)
EPA Substance Registry System: (3S-trans)-3-((6-bromo-1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine(960287-36-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 960287-36-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

960287-36-9 Suppliers

Recommended suppliersmore

960287-36-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 960287-36-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,6,0,2,8 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 960287-36:
(8*9)+(7*6)+(6*0)+(5*2)+(4*8)+(3*7)+(2*3)+(1*6)=189
189 % 10 = 9
So 960287-36-9 is a valid CAS Registry Number.

960287-36-9Upstream product

110429-35-1 (-)-paroxetine hydrochloride

960287-36-9Downstream Products

960287-36-9Relevant articles and documents

PSYCHOTROPIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE

-

Page/Page column 29-30, (2008/12/07)

The present invention provides a method for treating or preventing a disease or disorder treatable by the inhibition of serotonin reuptake in a patient, and/or norepinephrine reuptake and/or dopamine reuptake in a patient, the method comprising administer

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 960287-36-9